Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 7Sarcoma 2

Conditions

Dermatofibrosarcoma 2Skin Neoplasms 1Neoplasms, Adnexal and Skin Appendage 1Melanoma 1Histiocytoma, Malignant Fibrous 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1

Interventions

Radiotherapy 137Cyclophosphamide 132Temozolomide 116Doxorubicin 99Filgrastim 68Ifosfamide 64Gemcitabine 58Etoposide 55Bevacizumab 51Imatinib Mesylate 50fludarabine phosphate 49Irinotecan 46pembrolizumab 45Peripheral Blood Stem Cell Transplantation 45pazopanib 43Magnetic Resonance Spectroscopy 42Methotrexate 40Carboplatin 40Busulfan 40Vincristine 38Surgical Procedures, Operative 37Nivolumab 37Melphalan 37Cisplatin 36Radiation 34Blood Specimen Collection 33Mycophenolic Acid 31Cyclosporine 31Docetaxel 29Trabectedin 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Mohs Surgery × Sarcoma × Clear all
NCT03381846 2020-08-05

Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger

Mayo Clinic

Phase NA Completed
7 enrolled
Sarcoma

Dermatofibrosarcoma

NCT02310503 2020-05-05

REGESMOHS

Fundación Academia Española de Dermatología

Completed
6,000 enrolled
DermatologicSarcoma

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Melanoma, Skin Neoplasms, Dermatofibrosarcoma, Neoplasms, Adnexal and Skin Appendage, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡